A detailed history of Drw Securities, LLC transactions in Geron Corp stock. As of the latest transaction made, Drw Securities, LLC holds 106,638 shares of GERN stock, worth $119,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,638
Previous 97,453 9.43%
Holding current value
$119,434
Previous $137,000 6.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.1 - $1.47 $10,103 - $13,501
9,185 Added 9.43%
106,638 $146,000
Q2 2025

Aug 14, 2025

BUY
$1.18 - $1.62 $114,994 - $157,873
97,453 New
97,453 $137,000
Q2 2018

Aug 14, 2018

SELL
$3.29 - $4.82 $65,800 - $96,400
-20,000 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$1.81 - $5.98 $18,100 - $59,800
10,000 Added 100.0%
20,000 $85,000
Q2 2017

Aug 15, 2017

BUY
N/A
10,000
10,000 $28,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.